Yan Z - Search Results

1

Chemoproteomics Reveals That Quaternary Protoberberine Alkaloids Inhibit Telomerase Activity Oncologically by Binding to PES1.

Xu LW, Zhang XQ, Yan Z, Li ZH, Deng AJ, Qin HL. Xu LW, et al. Among authors: yan z. Chem Biodivers. 2023 May;20(5):e202300230. doi: 10.1002/cbdv.202300230. Epub 2023 Apr 4. Chem Biodivers. 2023. PMID: 36951446

2

Synthesis and Cytotoxicity Assessment against Human Colorectal Cancer Cell Lines of Quaternary 8-Dichloromethyl Protoberberine Alkaloids.

Xu LW, Zhang XQ, Yan Z, Li ZH, Deng AJ, Qin HL. Xu LW, et al. Among authors: yan z. Chem Biodivers. 2023 Jun;20(6):e202300570. doi: 10.1002/cbdv.202300570. Epub 2023 Jun 1. Chem Biodivers. 2023. PMID: 37194166

3

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.

Zhang F, Zhang R, Zong J, Hou Y, Zhou M, Yan Z, Li T, Gan W, Lv S, Yang L, Zeng Z, Zhao W, Yang M. Zhang F, et al. Among authors: yan z. Front Immunol. 2023 Oct 19;14:1279789. doi: 10.3389/fimmu.2023.1279789. eCollection 2023. Front Immunol. 2023. PMID: 37928532 Free PMC article.

4

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.

Zhou M, Lv S, Hou Y, Zhang R, Wang W, Yan Z, Li T, Gan W, Zeng Z, Zhang F, Yang M. Zhou M, et al. Among authors: yan z. Front Immunol. 2022 Oct 18;13:994874. doi: 10.3389/fimmu.2022.994874. eCollection 2022. Front Immunol. 2022. PMID: 36330513 Free PMC article.

5

Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.

Zhang R, Gan W, Zong J, Hou Y, Zhou M, Yan Z, Li T, Lv S, Zeng Z, Wang W, Zhang F, Yang M. Zhang R, et al. Among authors: yan z. Front Immunol. 2023 Feb 22;14:1054700. doi: 10.3389/fimmu.2023.1054700. eCollection 2023. Front Immunol. 2023. PMID: 36911744 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 37785700

7

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Gan W, Wang W, Li T, Zhang R, Hou Y, Lv S, Zeng Z, Yan Z, Yang M. Gan W, et al. Among authors: yan z. J Cancer. 2022 Mar 6;13(5):1588-1602. doi: 10.7150/jca.66949. eCollection 2022. J Cancer. 2022. PMID: 35371307 Free PMC article.

8

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

Li T, Yan Z, Wang W, Zhang R, Gan W, Lv S, Zeng Z, Hou Y, Yang M. Li T, et al. Among authors: yan z. Front Mol Biosci. 2021 Dec 6;8:687319. doi: 10.3389/fmolb.2021.687319. eCollection 2021. Front Mol Biosci. 2021. PMID: 34938771 Free PMC article.

9

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Li T, Wang W, Gan W, Lv S, Zeng Z, Hou Y, Yan Z, Zhang R, Yang M. Li T, et al. Among authors: yan z. Aging (Albany NY). 2022 Feb 14;14(3):1508-1528. doi: 10.18632/aging.203894. Epub 2022 Feb 14. Aging (Albany NY). 2022. PMID: 35157609 Free PMC article.

10

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.

Hou Y, Zhang R, Zong J, Wang W, Zhou M, Yan Z, Li T, Gan W, Lv S, Zeng Z, Yang M. Hou Y, et al. Among authors: yan z. Front Immunol. 2022 May 31;13:892512. doi: 10.3389/fimmu.2022.892512. eCollection 2022. Front Immunol. 2022. PMID: 35711437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,391 results

Search Page